GENESIS Pharma
Kiki Karvounis serves as the Medical Manager for Hematology/Oncology at Genesis Pharma, overseeing multiple markets including Greece, Cyprus, and the Balkans since February 2008. In this role, Kiki acts as the International Medical Lead, delivering comprehensive medical training and executing strategic Medical Affairs plans. Kiki has forged strong collaborations with various medical communities and international partners, managing a diverse portfolio of hematology and oncology products. Key achievements include the development of the COSMOS clinical trials monitoring tool and leading successful local company-sponsored studies. Prior experience includes roles at Roche as a Product Specialist and Clinical Research Associate, complemented by educational credentials in Healthcare Administration and Molecular Biology from respected institutions.
This person is not in any offices
GENESIS Pharma
GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. For more information, please visit www.genesispharmagroup.com and www.genesispharma.com